Saad Z. Usmani, on the Approval of Daratumumab and Hyaluronidase-fihj

The hematologist and medical oncologist discussed the approval of daratumumab and hyaluronidase-fihj for use in adult patients with newly diagnosed or relapsed/refractory multiple myeloma.

Source: CancerNetwork - May 18, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news